Navigation Links
PRA International to Present Audioconference on Oncology Research - Nov. 8
Date:10/23/2007

PRA Oncology Expert to Speak

RESTON, Va., Oct. 23 /PRNewswire-FirstCall/ -- PRA International (Nasdaq: PRAI) today announced that Dr. Ute Berger, the company's senior director of therapeutic expertise and a specialist in oncology and hematology, will present a one-hour audioconference on conducting global clinical research in oncology on Thursday, Nov. 8, 2007 at 11:30 a.m. EST. In "Challenges in Conducting Global Oncology Trials," Dr. Berger will recommend ways to mitigate risk in terms of timelines and costs.

The audioconference will be of special interest to leaders in pharmaceutical and biotechnology research and development, clinical development, operations, clinical studies, outsourcing, procurement, and global data management. The registration fee is US$199 per phone line. For more information and to register, go to http://www.fxtrans.com/resources/ac/future/ac20071108.htm.

The speaker earned her medical degree from Germany's University of Heidelberg where she has served in senior positions on the Faculty of Clinical Medicine for nearly 20 years. Dr. Berger holds medical certifications in internal medicine, oncology and hematology, and is certified by the European Society of Medical Oncology. She has held numerous high-visibility positions, including as medical coordinator for the German CML Study Group, general manager of the German Competence Network "Acute and Chronic Leukemias" and scientific network manager of the "European LeukemiaNet."

Dr. Berger has established relationships with key opinion leaders in the hematology/oncology field around the world. Widely published, she is known for her expertise in clinical research and has significant experience overseeing, directing and implementing global oncology trials in a variety of indications.

The audioconference is presented in cooperation with ForeignExchange Translations, Inc., the leader in providing linguistic services to medical device, pharmaceutical and biotech companies.

About PRA International

PRA International is one of the world's leading global clinical development organizations, with over 2,700 employees working from offices in North America, Europe, Asia, South America, Africa and Australia. PRA is committed to delivering reliable service, program-level therapeutic expertise, easy, global access to knowledge and an involved senior management.

To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (703) 464-6300.


'/>"/>
SOURCE PRA International
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... ... Executives 2017 in its continued commitment to the advancement of the clinical trials ... current issues related to clinical trial planning and management. , As executive ...
(Date:1/18/2017)... ... January 18, 2017 , ... Announced in December 2016, RoosterBio ... U.S. Secretary of Commerce Penny Pritzker has announced the award of a new ... has announced the award of a new Advanced Regenerative Manufacturing Institute (ARMI). These ...
(Date:1/18/2017)... PA (PRWEB) , ... January 18, 2017 , ... ... operations again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency ... engaging panel discussions to examine vital clinical research issues such as trial performance ...
(Date:1/18/2017)... , ... January 18, 2017 , ... Thirty-six startup companies ... credits by the Pennsylvania Department of Community and Economic Development in 2016 as part ... located in the University City Keystone Innovation Zone and represent the highest number of ...
Breaking Biology Technology:
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
(Date:12/12/2016)... CLEVELAND , Dec. 12, 2016  Researchers ... commercial possibilities for graphene by combining the material ... a highly sensitive pressure detector able to sense ... of a small spider.  The ... and can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/8/2016)... 2016  Singulex, Inc., the leader in Next Generation ... a license and supply agreement with Thermo Fisher Scientific, ... Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), a ... used to diagnose systemic bacterial infection and sepsis and ... aid in assessing the risk of critically ill patients ...
Breaking Biology News(10 mins):